Automated RIBA™ HCV strip immunoblot assay: A novel tool for the diagnosis of hepatitis C virus infection in hemodialysis patients

American Journal of Nephrology

Volumn 21, Issue 2, 2001, Pages 104-111

  Fabrizi, F ^a,c   Martin, P ^a   Dixit, V ^a   Quan, S ^b   Brezina, M ^a   Kaufman, E ^b   Sra, K ^b   Mousa, M ^a   DiNello, R ^b   Polito, A ^b   Gitnick, G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Anti HCV antibodies; Automated technique; Hemodialysis patients; Supplemental tests

Indexed keywords

IMMUNOGLOBULIN G; VIRUS RNA;

ADULT; AGED; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; INTERMETHOD COMPARISON; KIDNEY DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS DIAGNOSIS; VIRUS HEPATITIS; COMPARATIVE STUDY; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; RENAL REPLACEMENT THERAPY; TEST STRIP;

HEPATITIS C, CHRONIC; HUMANS; IMMUNOBLOTTING; MIDDLE AGED; REAGENT STRIPS; RENAL DIALYSIS;

EID: 17744386149     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046232     Document Type: Article

References (48)

1. Carrera F, Silva JG, Oliveira C, Frazao JM, Pires C: Persistence of antibodies to hepatitis C virus in a chronic hemodialysis population. Nephron 1994;68:38-40.
2. Fabrizi F, Bacchini G, Raffaele L, Erba GF, Locatelli F: Anti-HCV antibodies and transaminase concentrations in hemodialysis patients: A study with second-generation assays. Nephrol Dial Transplant 1993;8:740-743.
3. Chaveau P, Couroucè AM, Lemarec N, Naret C, Poignet JL, Girault A, Ramdane M, Delons S: Antibodies to hepatitis C virus by second generation test in hemodialyzed patients. Kidney Int 1993;43(suppl 41):149-152.
4. Getzug T, Lindsay K, Brezina M, Gitnick G: Hepatitis C virus antibody in hemodialysis patients: Prevalence and risk factors. Lancet 1990;335:589.
5. Vitale C, Tricerri A, Marangella M, Vacha GM, Giorcelli G, Marini C, Molinaro G. Cosseddu D, Linari F: Epidemiology of hepatitis C virus infection in dialysis units: First-versus second-generation assays. Nephron 1993;64: 315-316.
6. De Medina M, Larue S, Hill M, O'Sullivan H, Pennell JP, Leclerq B, Li X, Jeffers L, Parker T, Reddy KR, Schiff ER, Perez GO: Quantitative detection of hepatitis C virus RNA in patients undergoing hemodialysis. ASAIO J 1997;43: 19-22.
7. Hardy NM, Sandroni S, Danielson S, Wilson WJ: Antibody to hepatitis C virus increases with time on hemodialysis. Clin Nephrol 1992; 38:44-48.
8. Knudsen F, Wandzin P, Rasmussen K, Ladefoged SD, Lokkegaard N, Rasmussen LS, Lassen A, Krogsgaard K: Hepatitis C in dialysis patients: Relationship to blood transfusions, dialysis and liver disease. Kidney Int 1993;43: 1353-1356.
9. Mondelli MU, Cristina G, Piazza V, Cerino A, Villa G, Salvadeo A: High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second-generation assay. Nephron 1992;61:350-351.
10. Besso L, Rovere A, Peano G, Menardi G, Fenoglio LM, Ghezzi PM: Prevalence of HCV antibodies in a uraemic population undergoing maintenance dialysis therapy and in the staff members of the dialysis unit. Nephron 1992; 61:304-306.
11. Sheu JC, Lee SH, Wang JT, Shih LN, Wang TH, Chen DS: Prevalence of anti-HCV and HCV viremia in hemodialysis patients in Taiwan. J Med Virol 1992;37:108-112.
12. Jadoul M, Cornu C, van Ypersele de Strihou C, and Universitaires Cliniques St-Luc (UCL) Collaborative Group: Universal precautions prevent hepatitis C virus transmission: A 54 month follow-up of the Belgian Multicenter Study. Kidney Int 1998;53:1022-1025.
13. Allander T, Medin C, Jacobson SH, Grillner L, Persson MAA: Hepatitis C transmission in a hacmodialysis unit: Molecular evidence for spread of virus among patients not sharing equipment. J Med Virol 1994;43:415-419.
14. Grethe S, Gemsa F, Monazahian M, Bohme I, Uy A, Thomssen R: Molecular epidemiology of an outbreak of HCV in a hemodialysis unit: Direct sequencing of HCV-HVR1 as an appropriate tool for phylogenetic analysis. J Med Virol 2000;60:152-158.
15. Irish DN, Blake C, Christophers J, Craske JE, Burnapp L, Abbs IC, MacMahon EM, Muir P, Banatvala JE, Simmonds P: Identification of hepatitis C virus seroconversion resulting from nosocomial transmission on a haemodialysis unit: Implications for infection control and laboratory screening. J Med Virol 1999;59:135-140.
16. Izopet J, Pasquier C, Sandres K, Puel J, Rostaing L: Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit. J Med Virol 1999;58:139-144.
17. Katsoulidou A, Paraskevis D, Kalapothaki V, Arvanitis D, Karayannis P, Hadjiconstantinou V, Hatkakis A for the Multicentre Haemodialysis Cohort Study on Viral Hepatitis: Molecular epidemiology of a hepatitis C virus outbreak in a hemodialysis unit. Nephrol Dial Transplant 1999;14:1188-1194.
18. Le Pogam S, Le Chapois D, Christen R, Dubois F, Barin F, Goudeau A: Hepatitis C in a hemodialysis unit: Molecular evidence for nosocomial transmission. J Clin Microbiol 1998;36: 2926-2931.
19. Mizuno M, Higuchi T, Kanmatsuse K, Esumi M: Genetic and serological evidence for multiple instances of unrecognized transmission of hepatitis C in haemodialysis units. J Clin Microbiol 1998;36:2916-2931.
20. Caramelo C, de Sequera P, López MD, Ortiz A: Hand-borne mechanisms of dissemination of hepatitis C in dialysis units: Basis for new addenda to the present preventive strategies. Clin Nephrol 1999;51:59-60.
21. Jimenez DA, Sanchez-Paya J, Gonzales C, Rivera F, Antolin A: Audit on the degree of application of universal precautions in a haemodialysis unit. Nephrol Dial Transplant 1999;14: 1001-1003.
22. Salama G, Rostaing L, Sandres K, Izopet J: Hepatitis C virus infection in French hemodialysis units: A multicenter study. J Med Virol 2000;61:44-51.
23. Lombardi M, Cerrai T, Geatti S, Negroni S, Pertusini L, Pegoraro M, Di Lullo G: Results of a national epidemiological investigation on HCV infection among dialysis patients. J Nephrol 1999;12:322-327.
24. Covic A, Iancu I, Apetrei C, Scripcaru D, Volovat C, Mititiuc I, Covic M: Hepatitis virus infection in haemodialysis patients from Moldavia. Nephrol Dial Transplant 1999;14:40-45.
25. Djordjevic V, Stojanovic C, Stojanovic M, Stefanovic V: Prevention of nosocomial transmission of hepatitis C infection in a hemodialysis unit: A prospective study. Int J Artif Organs 2000;23:181-188.
26. Rais-Jalali G, Khajehdehi P: Anti-HCV seropositivity among haemodialysis patients of Iranian origin. Nephrol Dial Transplant 1999; 14:2055-2056.
27. Sayiner AA, Zeytinoglu A, Ozkahya M, Erensoy S, Ozacar T, Ok E, Akcicek F, Bilgic A: HCV infection in haemodialysis and CAPD patients. Nephrol Dial Transplant 1999;14: 256-257.
28. Todorov V, Boneva R, Ilieva P, Doichinova T, Donchev M: High prevalence of hepatitis C virus infection in one dialysis center in Bulgaria. Nephron 1998;79:222-223.
29. Zamir D, Storch S, Zonder HB, Zamir C, Weiner P: Hepatitis C virus seroconversion and genotype prevalence in patients and staff on chronic hemodialysis. J Clin Gastroenterol 1999;28:23-28.
30. CDC: Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998;47:1-39.
31. Zaajer HL, Cuypers HT, Reesink HW, Gerken G, Lelie PN: Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993;341:722-724.
32. Fabrizi F, Lunghi G, Raffaele L, Guarnori I, Bacchini G, Corti M, Pagano A, Erba GF, Locatelli F: Serologic survey for control of hepatitis C in haemodialysis patients: Third-generation assays and analysis of costs. Nephrol Dial Transplant 1997;12:298-303.
33. Couroucè AM, Bourchardeau F, Chaveau P, Le Marrec N, Girault A, Zins B, Naret C, Poignet JL: Hepatitis C virus (HCV) infection in haemodialysis patients: HCV RNA and anti-HCV antibodies (third-generation assays). Nephrol Dial Transplant 1995;10:234-239.
34. Uyttendaele S, Claeys H, Maertens W, Verhaert H, Vermylen C: Evaluation of third-generation screening and confirmatory assays for HCV antibodies. Vox Sang 1994;66:122-129.
35. Vernelen K, Claeys H, Verhaert H, Volckaerts A, Vermylen C: Significance of NS3 and NS5 antigens in screening for HCV antibody. Lancet 1994;343:853.
36. Buffet C, Charnaux N, Laurent-Puig N, Chopineau S, Quichon JP, Briantais MJ, Dussaix E: Enhanced detection of antibodies to hepatitis C virus by use of a third generation recombinant immunoblot assay. J Med Virol 1994;43:259-261.
37. Van der Poel CL, Cuypers HTM, Reesink HW: Hepatitis C virus six years on. Lancet 1994; 344:1475-1479.
38. Van der Poel CL, Cuypers HTM, Reesink HW, Weiner AJ, Quan S, DiNello R, van Boven JJP, Winkel I, Mulder-Folkerts D, Exel-Oehlers PJ, Schaasberg W, Leentvar-Kuypers A, Polito A, Houghton M, Lelie PN: Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 1991; 337:317-319.
39. Skidmore S: Recombinant immunoblot assay for hepatitis C antibody. Lancet 1991;337: 317-319.
40. Martin P, Fabrizi F, Dixit V, Quan S, Brezina M, Kaufman E, Sra K, DiNello R, Polito A, Gitnick G: Automated RIBA™ HCV Strip Immunoblot Assay for reproducible diagnosis. J Clin Microbiol 1998;36:387-390.
41. Icardi G, Bonanni P, Raffo AM, Masini A, Orione L, De Martini M, Crovari P: Evaluation of performance of the RIBA processor system for automated analysis of the strip immunoblot assay for detection of antibodies to hepatitis C virus. J Clin Microbiol 1997;35:2231-2236.
42. Martin P, Fabrizi F, Dixit V, Brezina M, Conrad A, Russell J, Gitnick G: Epidemiology and natural history of hepatitis G virus infection in chronic hemodialysis patients. Am J Nephrol 1999;19:535-540.
43. Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Gerosa S, Vinson S, Mousa M, Gitnick G: Quantitative assessment of HCV load in chronic hemodialysis patients: A cross-sectional survey. Nephron 1998;80:428-434.
44. Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Gerosa S, Vinson S, Mousa M, Gitnick G: Acquisition of hepatitis C virus in hemodialysis patients: A prospective study by branched DNA (bDNA) signal amplification assay. Am J Kidney Dis 1998;31:647-654.
45. Landis JR, Koch CG: The measurement of observer agreement for categorical data. Biometrics 1997;33:159-174.
46. Griner PF, Mayewski RJ, Mushlin AI, Greeland P: Selection and interpretation of diagnostic tests and procedures. Ann Intern Med 1981; 94:553-600.
47. Dixit V, Quan S, Martin P, Larson D, Brezina M, Di Nello R, Sra K, Lau JYN, Chien D, Kolberg J, Tagger A, Davis G, Polito A, Gitnick G: Evaluation of a novel serotyping system for hepatitis C virus: Strong correlation with standard genotyping methodologies. J Clin Microbiol 1995;33:2978-2983.
48. Tokars JI, Miller ER, Alter MJ, Arduino MJ: National surveillance of dialysis associated diseases in the United States, 1995. ASAIO J 1998;44:98-107.